Frankfurt - Delayed Quote EUR

Perimeter Medical Imaging AI, Inc. (4PC.F)

0.2060
-0.0100
(-4.63%)
As of 8:03:07 AM GMT+2. Market Open.
Loading Chart for 4PC.F
  • Previous Close 0.2160
  • Open 0.2060
  • Bid 0.2060 x --
  • Ask 0.2860 x --
  • Day's Range 0.2060 - 0.2060
  • 52 Week Range 0.1960 - 0.5200
  • Volume 2,323
  • Avg. Volume 0
  • Market Cap (intraday) 21.952M
  • Beta (5Y Monthly) 1.86
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1700
  • Earnings Date May 13, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Perimeter Medical Imaging AI, Inc., a medical technology company, provides advanced imaging tools that address unmet medical needs. The company offers Perimeter S-Series optical coherence tomography (OCT) imaging system that delivers resolution margin visualization of excised tissue specimens in the operating room. It also develops Perimeter B-series OCT with ImgAssist artificial intelligence technology for patients undergoing breast conservation surgery. In addition, the company offers a proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. is based in Toronto, Canada.

perimetermed.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4PC.F

View More

Performance Overview: 4PC.F

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

4PC.F
17.60%
S&P/TSX Composite index (^GSPTSE)
2.57%

1-Year Return

4PC.F
37.58%
S&P/TSX Composite index (^GSPTSE)
12.86%

3-Year Return

4PC.F
87.50%
S&P/TSX Composite index (^GSPTSE)
26.27%

5-Year Return

4PC.F
78.18%
S&P/TSX Composite index (^GSPTSE)
68.74%

Compare To: 4PC.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4PC.F

View More

Valuation Measures

As of 5/8/2025
  • Market Cap

    23.02M

  • Enterprise Value

    17.67M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    20.63

  • Price/Book (mrq)

    2.18

  • Enterprise Value/Revenue

    23.61

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -67.06%

  • Return on Equity (ttm)

    -104.97%

  • Revenue (ttm)

    990.97k

  • Net Income Avi to Common (ttm)

    -13.39M

  • Diluted EPS (ttm)

    -0.1700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.18M

  • Total Debt/Equity (mrq)

    1.32%

  • Levered Free Cash Flow (ttm)

    -13.1M

Research Analysis: 4PC.F

View More